Aura Biosciences, Inc. financial data

Symbol
AURA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
80 Guest Street, Boston, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.83 K % +1.33%
Debt-to-equity 14.6 % +2.6%
Return On Equity -41.8 % -2.18%
Return On Assets -36.5 % -1.84%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.5 M shares +31%
Common Stock, Shares, Outstanding 49.5 M shares +31%
Entity Public Float 225 M USD -19.8%
Weighted Average Number of Shares Outstanding, Basic 49.5 M shares +30.9%
Weighted Average Number of Shares Outstanding, Diluted 49.5 M shares +30.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 67.9 M USD +40.3%
General and Administrative Expense 20 M USD +7.65%
Operating Income (Loss) -87.9 M USD -31.3%
Nonoperating Income (Expense) 9.4 M USD +166%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -19.7 M USD -12.6%
Income Tax Expense (Benefit) 46 K USD
Net Income (Loss) Attributable to Parent -78.6 M USD -24.1%
Earnings Per Share, Basic -1.87 USD/shares +5.56%
Earnings Per Share, Diluted -1.87 USD/shares +5.56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 26.3 M USD -31.7%
Cash, Cash Equivalents, and Short-term Investments 149 M USD +33.7%
Other Assets, Current 2.29 M USD +197%
Assets, Current 212 M USD +18.5%
Property, Plant and Equipment, Net 3.05 M USD -40.9%
Operating Lease, Right-of-Use Asset 18.5 M USD -9.04%
Other Assets, Noncurrent 453 K USD -27.3%
Assets 235 M USD +14.1%
Accounts Payable, Current 1.93 M USD +83.2%
Liabilities, Current 9.66 M USD +19.2%
Operating Lease, Liability, Noncurrent 16.6 M USD -6.09%
Liabilities 26.2 M USD +1.87%
Accumulated Other Comprehensive Income (Loss), Net of Tax 18 K USD
Retained Earnings (Accumulated Deficit) -307 M USD -34.4%
Stockholders' Equity Attributable to Parent 209 M USD +15.8%
Liabilities and Equity 235 M USD +14.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -24.5 M USD -49%
Net Cash Provided by (Used in) Financing Activities 253 K USD +25.9%
Net Cash Provided by (Used in) Investing Activities 9.4 M USD
Common Stock, Shares Authorized 150 M shares 0%
Common Stock, Shares, Issued 49.5 M shares +31%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -14.8 M USD +82.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 27 M USD -31.1%
Deferred Tax Assets, Valuation Allowance 81.9 M USD +36.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 87.3 M USD +32.7%
Operating Lease, Liability 19.3 M USD -6.39%
Depreciation 1.27 M USD +1.92%
Payments to Acquire Property, Plant, and Equipment 88 K USD -19.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -78.6 M USD -23.9%
Lessee, Operating Lease, Liability, to be Paid 29.7 M USD -10.4%
Property, Plant and Equipment, Gross 8.4 M USD -10.3%
Operating Lease, Liability, Current 2.74 M USD -8.17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.41 M USD +3.15%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.31 M USD +3.15%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 10.4 M USD -17.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.51 M USD +3.15%
Deferred Tax Assets, Operating Loss Carryforwards 46 M USD +13.3%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 137 K USD
Preferred Stock, Shares Authorized 10 M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.61 M USD +3.14%
Operating Lease, Payments 751 K USD -2.21%
Additional Paid in Capital 516 M USD +26.2%
Preferred Stock, Shares Outstanding 0 shares
Current Federal Tax Expense (Benefit) 137 K USD
Share-based Payment Arrangement, Expense 9.77 M USD +45.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares